mbp price action

Note my earlier comment of 4 Jan 2007-

"Given MBP is in effect doing a second phase IIb, the current test will have been designed so that there is virtually no possibility of not hitting the defined end points, given the deep understanding and research undertaken to date. AOD9604 efficacy and statistical significance I think is fairly certain at this point."

I know the management team @ MBP well and trust me they have never looked so relaxed, they know AOD9604 works and this time they won't have the staticstical problem of the last time,which was largely due to a too small sample size and a few too many people dropping out.

I doubt they would accept a takeover, their "scientific" egos are such that they want to run this as far as they can without giving away the shop. Don't forget the pain drug which looks very promising as well...

Only risk to price short term is Circadian dumping their holding...